0000000000671034
AUTHOR
S. Genovese
Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes
Background Albuminuria has been classically considered a marker of kidney damage progression in diabetic patients and it is routinely assessed to monitor kidney function. However, the role of a mild GFR reduction on the development of stage ≥3 CKD has been less explored in type 1 diabetes mellitus (T1DM) patients. Aim of the present study was to evaluate the prognostic role of kidney disease measures, namely albuminuria and reduced GFR, on the development of stage ≥3 CKD in a large cohort of patients affected by T1DM. Methods A total of 4284 patients affected by T1DM followed-up at 76 diabetes centers participating to the Italian Association of Clinical Diabetologists (Associazione Medici D…
Effects of Cucumber mosaic virus and Aster yellows phytoplasma (16SrI-B) on the quality of Echinacea purpurea essential oil.
Echinacea purpurea Moench (L.), known as purple coneflower, is one of the most important medicinal plants, used worldwide for its immunostimulant, bacteriostatic and anti-inflammatory properties, as natural drug and/or food supplement (as infusion). In a previous study carried out in 2002 in Italy to verify possible influence of viral infectious on the plant oil composition, the oil from plants (grown at the Herb Garden of Casola Valsenio, Emilia Romagna region) infected by Cucumber mosaic virus (CMV) was compared to the one from healthy plant by combined gas chromatography mass spectrometry (GC/MS) analyses. Significant quantitative variations in their compositions were verified; the infec…
Effects of Vildagliptin/Metformin Therapy on Patient-Reported Outcomes: Work Productivity, Patient Satisfaction, and Resource Utilization
Introduction: Type 2 diabetes mellitus (T2DM) is associated not only with high direct healthcare costs, but also with indirect costs, as diabetic complications and the disease itself result in loss of productivity. Vildagliptin is a novel dipeptidyl peptidase-4 inhibitor that is given either alone or in combination with oral hypoglycemic drugs, including metformin. The study was designed to assess the hypothesis that fixed-combination vildagliptin/metformin improves work productivity measured as Work Productivity and Activity Impairment (WPAI) scores. Secondary objectives were the assessment of patient satisfaction by means of the Diabetes Treatment Satisfaction Questionnaire (DTSQs), the c…